Organon & Co | OGN - Market Capitalization


Organon & Co reported $3.52B in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Celltrion KRW 42.67T 40.86T Oct/2026
Cspc Pharmaceutical CNY 103.79B 16.5B Mar/2026
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 4.58B 2.8B Mar/2026
Divis Laboratories Ltd INR 1.75T 167.78B Jun/2026
Gilead Sciences USD 196.01B 39.15B Oct/2026
Glaxosmithkline GBP 109.29B 9.36B Mar/2026
Kangmei Pharma CNY 16.59B 7.89B Jun/2026
Laboratorios Farma EUR 4.17B 917.16M Mar/2026
Malin Corporation EUR 133.52M 29.05M Aug/2026
Medical Developments International AUD 62.53M 563.29K Dec/2025
Merck USD 317.37B 20.27B Jun/2026
Neuren Pharmaceuticals AUD 2.36B 606.56M Dec/2025
Novartis USD 288.26B 25.18B Mar/2026
Organigram Holdings CAD 252.47M 59.69M Mar/2026
Organon & Co USD 3.56B 1.99B Jun/2026
Ovoca Bio EUR 1.17M 18.38K Dec/2025
Pharma Mar EUR 1.31B 263.2M Jun/2026
Qiagen NV USD 8.07B 197.36M Jun/2026
Sartorius EUR 9.66B 7.77B Oct/2026
Zealand Pharma A/S 20.84B 12.51B Mar/2026